|
1. “A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping”
by Maria Romano, Alessia Ruggiero, Flavia Squeglia, Giovanni Maga and Rita Berisio
Cells 2020, 9(5), 1267; https://doi.org/10.3390/cells9051267
Available online: http://www.mdpi.com/2073-4409/9/5/1267
|
|
2. “COVID-19, Renin-Angiotensin System and Endothelial Dysfunction”
by Razie Amraei and Nader Rahimi
Cells 2020, 9(7), 1652; https://doi.org/10.3390/cells9071652
Available online: http://www.mdpi.com/2073-4409/9/7/1652
|
|
3. “Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19”
by Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain, Pankaj Kumar Chaudhary, Supriya Khanra, Puneet Dhamija, Ambika Sharma, Ashish Kumar and Shailendra Handu
Cells 2021, 10(4), 821; https://doi.org/10.3390/cells10040821
Available online: http://www.mdpi.com/2073-4409/10/4/821
|
|
4. “Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2”
by Ma’mon M. Hatmal, Walhan Alshaer, Mohammad A. I. Al-Hatamleh, Malik Hatmal, Othman Smadi, Mutasem O. Taha, Ayman J. Oweida, Jennifer C. Boer, Rohimah Mohamud and Magdalena Plebanski
Cells 2020, 9(12), 2638; https://doi.org/10.3390/cells9122638
Available online: http://www.mdpi.com/2073-4409/9/12/2638
|
|
5. “Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness”
by Zuzana Parackova, Irena Zentsova, Marketa Bloomfield, Petra Vrabcova, Jitka Smetanova, Adam Klocperk, Grigorij Mesežnikov, Luis Fernando Casas Mendez, Tomas Vymazal and Anna Sediva
Cells 2020, 9(10), 2206; https://doi.org/10.3390/cells9102206
Available online: http://www.mdpi.com/2073-4409/9/10/2206
|
|
6. “Cardiovascular Manifestations of COVID-19 Infection”
by Ajit Magadum and Raj Kishore
Cells 2020, 9(11), 2508; https://doi.org/10.3390/cells9112508
Available online: http://www.mdpi.com/2073-4409/9/11/2508
|
|
7. “ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients”
by Alice G. Vassiliou, Chrysi Keskinidou, Edison Jahaj, Parisis Gallos, Ioanna Dimopoulou, Anastasia Kotanidou and Stylianos E. Orfanos
Cells 2021, 10(1), 186; https://doi.org/10.3390/cells10010186
Available online: http://www.mdpi.com/2073-4409/10/1/186
|
|
8. “Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection”
by Nazzarena Labò, Hidetaka Ohnuki and Giovanna Tosato
Cells 2020, 9(7), 1583; https://doi.org/10.3390/cells9071583
Available online: http://www.mdpi.com/2073-4409/9/7/1583
|
|
9. “SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response”
by Soo Jin Oh and Ok Sarah Shin
Cells 2021, 10(3), 530; https://doi.org/10.3390/cells10030530
Available online: http://www.mdpi.com/2073-4409/10/3/530
|
|
10. “SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway”
by Daria Bortolotti, Valentina Gentili, Sabrina Rizzo, Antonella Rotola and Roberta Rizzo
Cells 2020, 9(9), 1975; https://doi.org/10.3390/cells9091975
Available online: http://www.mdpi.com/2073-4409/9/9/1975
|
|
11. “A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2”
by Nina-Naomi Kreis, Andreas Ritter, Frank Louwen and Juping Yuan
Cells 2020, 9(8), 1777; https://doi.org/10.3390/cells9081777
Available online: http://www.mdpi.com/2073-4409/9/8/1777
|
|
12. “Canonical and Noncanonical Autophagy as Potential Targets for COVID-19”
by Melissa Bello-Perez, Isabel Sola, Beatriz Novoa, Daniel J. Klionsky and Alberto Falco
Cells 2020, 9(7), 1619; https://doi.org/10.3390/cells9071619
Available online: http://www.mdpi.com/2073-4409/9/7/1619
|
|
13. “Taming the Autophagy as a Strategy for Treating COVID-19”
by Blanca Estela García-Pérez, Juan Antonio González-Rojas, Ma Isabel Salazar, Carlos Torres-Torres and Nayeli Shantal Castrejón-Jiménez
Cells 2020, 9(12), 2679; https://doi.org/10.3390/cells9122679
Available online: http://www.mdpi.com/2073-4409/9/12/2679
|
|
14. “Significance of NETs Formation in COVID-19”
by Karolina Janiuk, Ewa Jabłońska and Marzena Garley
Cells 2021, 10(1), 151; https://doi.org/10.3390/cells10010151
Available online: http://www.mdpi.com/2073-4409/10/1/151
|
|
15. “An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms”
by Melvin R Hayden
Cells 2020, 9(11), 2475; https://doi.org/10.3390/cells9112475
Available online: http://www.mdpi.com/2073-4409/9/11/2475
|
|
16. “Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats”
by Marco Malavolta, Robertina Giacconi, Dario Brunetti, Mauro Provinciali and Fabrizio Maggi
Cells 2020, 9(4), 909; https://doi.org/10.3390/cells9040909
Available online: http://www.mdpi.com/2073-4409/9/4/909
|
|
17. “The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies”
by Anastassios C. Papageorgiou and Imran Mohsin
Cells 2020, 9(11), 2343; https://doi.org/10.3390/cells9112343
Available online: http://www.mdpi.com/2073-4409/9/11/2343
|
|
18. “A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries”
by Shiming Peng, Wei Li, Nannan Hou and Niu Huang
Cells 2020, 9(1), 184; https://doi.org/10.3390/cells9010184
Available online: http://www.mdpi.com/2073-4409/9/1/184
|
|
19. “Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review”
by Fien Demeulemeester, Karin de Punder, Marloes van Heijningen and Femke van Doesburg
Cells 2021, 10(4), 933; https://doi.org/10.3390/cells10040933
Available online: http://www.mdpi.com/2073-4409/10/4/933
|
|
20. “New Onset of Autoimmune Diseases Following COVID-19 Diagnosis”
by Abraham Edgar Gracia-Ramos, Eduardo Martin-Nares and Gabriela Hernández-Molina
Cells 2021, 10(12), 3592; https://doi.org/10.3390/cells10123592
Available online: http://www.mdpi.com/2073-4409/10/12/3592
|
|
21. “Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients”
by María Elena Soto, Verónica Guarner-Lans, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Alfredo Aisa-Álvarez, Huitzilihuitl Saucedo-Orozco and Israel Pérez-Torres
Cells 2022, 11(6), 932; https://doi.org/10.3390/cells11060932
Available online: http://www.mdpi.com/2073-4409/11/6/932
|
|
22. “Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations”
by Jonathan D. Ravid, Orly Leiva and Vipul C. Chitalia
Cells 2022, 11(2), 306; https://doi.org/10.3390/cells11020306
Available online: http://www.mdpi.com/2073-4409/11/2/306
|
|
23. “Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery”
by Tine Tricot, Catherine M. Verfaillie and Manoj Kumar
Cells 2022, 11(3), 442; https://doi.org/10.3390/cells11030442
Available online: http://www.mdpi.com/2073-4409/11/3/442
|
|
24. “Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies”
by Sascha Berlansky, Matthias Sallinger, Herwig Grabmayr, Christina Humer, Andreas Bernhard, Marc Fahrner and Irene Frischauf
Cells 2022, 11(2), 253; https://doi.org/10.3390/cells11020253
Available online: http://www.mdpi.com/2073-4409/11/2/253
|
|
25. “Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants”
by Kyonghwan Choe, Hyun Young Park, Muhammad Ikram, Hyeon Jin Lee, Tae Ju Park, Rahat Ullah and Myeong Ok Kim
Cells 2022, 11(8), 1298; https://doi.org/10.3390/cells11081298
Available online: http://www.mdpi.com/2073-4409/11/8/1298
|
